Tumor ablation is a minimally invasive surgical procedure used to treat solid cancers. Factors such as rising prevalence of different forms of cancer, technological  advancements in the field of ablation, rising awareness regarding the benefits offered by ablation procedures over conventional surgical procedures and rising number of hospitals, surgical and ablation centers are driving the growth of tumor ablation market globally.

The report titled “Tumor Ablation Market - Growth, Future Prospects and Competitive Analysis, 2017–2025” offers strategic insights into the overall tumor ablation market along with the market size and estimates for the duration 2015 to 2025. The research study covers in-depth analysis of market segments based on technology radiofrequency ablation, microwave ablation, cryoablation and other technologies, treatment surgical ablation, laparoscopic ablation and percutaneous ablation, application liver cancer, lung cancer, kidney cancer, bone metastasis and other applications and different geographical regions. Geographically, the global tumor ablation market is studied for the following regional markets:  

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • Rest of Asia Pacific
• Latin America
• Middle East and Africa

Market size and forecast for these regional and country level markets are presented in this study for the period 2015-2025. Market growth rates for the forecast period 2017-2025 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global tumor ablation market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global tumor ablation market. This report concludes with company profiles section that highlights major information about the key players engaged in global tumor ablation market. In-depth competitive environment analysis and historical years (2015) market size data are also provided in the report. Thus, the research study provides a holistic view of the global tumor ablation market, offering market size and estimates for the period from 2015 to 2025, keeping in mind the above-mentioned factors.   

Based on technology, the global tumor ablation market is segmented as follows:

• Radiofrequency ablation
• Microwave ablation
• Cryoablation
• Other Technology

Tumor ablation is a minimally invasive surgical procedure used to treat solid cancers, special probes are used to burn or freeze tumor without performing conventional surgery. These treatments are also sometimes perform in patients waiting for a liver transplant. Factors such as rising prevalence of different forms of cancer, growing number of hospitals, surgical, and ablation centers, technological advancements in ablation devices and growing adoption of tumor ablation procedures are driving the growth of tumor ablation market globally. It is observed that in the base year 2016, radiofrequency ablation held largest market share and it is anticipated that it will grow at highest CAGR during forecast period due to factors such as less risk of tissue damage, widely accepted method for small tumors and faster recovery would influence the growth of radiofrequency ablation market globally. Radiofrequency ablation is commonly used to treat cancer in bone, kidney, liver, lung and prostate.

Based on treatment, the global tumor ablation market is segmented as follows:

• Surgical ablation
• Laparoscopic ablation
• Percutaneous ablation

Ablation refers to removal tissue from the body; tumor ablation is a minimally invasive surgical procedure used to treat solid cancers, special probes are used to burn or freeze tumor without the usual surgery. Factors such as increasing prevalence of different forms of cancer, rising demand for minimally invasive procedures, technological advancements in the field of ablation and rising number of hospitals, surgical and ablation centers are driving the growth of tumor ablation market globally. It is observed that in the base year 2016, surgical ablation held the largest market share due to factors such as rising prevalence of liver and breast cancer and increasing use of thoracoscopic surgical ablation are fueling the growth of surgical ablation market worldwide. There are different types of ablations and various techniques are used to perform the removal of tissue, depending on the nature of the issue. Surgical ablation may be performed with a laser or radio frequency emissions may be used.

Based on application, the global tumor ablation market is segmented as follows: 

• Liver cancer
• Lung cancer
• Kidney cancer
• Bone metastasis
• Other applications

Tumor ablation is a minimally invasive procedure that is commonly used in the treatment of tumors of liver, kidney, bone, and lung. Special probes are used to burn or freeze tumor without the usual surgery; these treatments are also sometimes performed in patients waiting for liver transplant. Factors such as rising prevalence of different forms of cancer, technological advancements in ablation devices and growing adoption of tumor ablation procedures are driving the growth of tumor ablation market globally. It is observed that, in the base year 2016, liver cancer is largest revenue generating segment because of increase in prevalence of liver cancer and tumor ablation is globally accepted procedure in treatment of solid tumors in liver for patient where surgical procedure is not possible or preferred. Tumor ablation are also sometimes performed in patients waiting for a liver transplant. Radiofrequency ablation is used primarily to shrink or slow down the growth of liver carcinoma; it is usually done as an outpatient procedure under light sedation.

For the purpose of this study, the global tumor ablation market is categorized into:

• North America
• Europe
• Asia Pacific
• Latin America (LATAM)
• Middle East and Africa (MEA)

In the base year 2016, North America dominated the tumor ablation market in terms of revenue and it is anticipated that it will show significant growth during forecast period. The U.S. was observed as the largest country-level market in North America. Factors such as increasing prevalence of different forms of cancer, advanced healthcare infrastructure, higher cost of therapy, technological advances and upsurge funding by the government are the prime contributors to the dominance of North America. It is anticipated that Asia Pacific will grow at the highest CAGR during the forecast period due to developing economic condition, improved treatment access, improvement in awareness among general patient population, rising medical expenditures in emerging economies such as India, China and Japan, growing market penetration of major players in this region would drive the market growth in Asia Pacific during forecast period 2017-2025.